Dr. Jisha K. Joshua, MD

Dr. Joshua practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Joshua's NPI, 1023436417, was assigned on April 2, 2014. Dr. Joshua graduated from Christian Medical College Vellore in 2008. Dr. Joshua holds California license A144956.

Dr. Joshua's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Joshua's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Joshua is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Joshua to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Joshua practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Joshua's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Joshua is board certified in internal medicine by the American Board of Internal Medicine. Dr. Joshua is licensed in California.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Joshua treats.

CMS data shows 1,448 Medicare services from Dr. Joshua across 13 procedure codes in 2024, for 524 Medicare patients. Medicare paid $72,558 for them.

CMS counts 524 Medicare patients who saw Dr. Joshua in 2024. The largest group is 65 to 74, with 224 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Joshua's median patient age at 62, with 51% women.

In 2024, Dr. Joshua wrote 1,653 Medicare Part D claims for 170 patients. 54% of them were for generic drugs. CMS names the drug for 1,474 of them, across 34 drugs with 11 or more claims each, at $2,605,703 in total drug cost. In 2023, CMS named 1,139 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Joshua for performance year 2024, reported as part of a group. Dr. Joshua accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Joshua as offering telehealth.

Dmand AI links 14 papers to Dr. Joshua, published from 2014 to 2023. 2014 was the busiest year, with 3. The most frequent topics are Cells, Cultured, Osteocytes and Cell Differentiation. Dr. Joshua's most frequent co-authors are Leeyen Hsu, Jeremy R. Beitler, MD and Tiffany B. Ghafouri, MD.

CMS Open Payments shows 18 general payments to Dr. Joshua from 4 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 66% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $3,230.

Dr. Joshua graduated from Christian Medical College Vellore in 2008.

Dr. Joshua is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.